Pharmaceutical ETF Market Vectors (PPH) 67.69 $PPH
Pfizer Set to Acquire Hospira: Healthcare ETFs in Focus - ETF News And Commentary
Sweta Killa - Zacks Investment Research - Fri Feb 06, 9:00AM CST
Healthcare ETFs are worth a look given that Pfizer will buy Hospira.
IHE: 163.48 (+1.38), PPH: 67.69 (+0.60), IYH: 149.63 (+0.84), PFE: 34.64 (-0.23), HSP: 87.35 (unch), XLV: 70.72 (+0.28)
Big Pharma Weak Guidance Put These ETFs in Focus - ETF News And Commentary
Sweta Killa - Zacks Investment Research - Thu Feb 05, 10:00AM CST
How pharma ETFs are looking after the string of earnings beat and disappointing guidance?
IHE: 163.48 (+1.38), JNJ: 99.62 (+1.18), PPH: 67.69 (+0.60), PJP: 73.81 (+0.69), MRK: 58.81 (-0.07), PFE: 34.64 (-0.23), LLY: 70.56 (+0.03), BMY: 60.04 (+0.56)
New Year Kicks Off With New Fears To Keep Investors On Edge
Scott Martindale - Seeking Alpha - Tue Jan 20, 4:47AM CST
As widely expected, the new year has begun with a lot of volatility on high trading volume, as investors fear more than just a mild correction to start out the year. Despite the strong fundamentals here in the U.S., there are plenty of dangers around...
IYK: 106.66 (-0.09), IYJ: 109.15 (+0.67), ACT: 285.37 (+3.71), IYH: 149.63 (+0.84), IYM: 86.13 (+0.83), UNH: 109.44 (-0.40), PSA: 202.61 (-1.18), IYC: 142.85 (+0.77), SMH: 56.39 (+0.33), NXPI: 84.79 (-0.60), IT: 81.53 (+1.64), IYF: 90.01 (-0.04), IYE: 46.47 (+0.95), LUV: 43.30 (-0.20), JLL: 161.15 (+0.18), PPH: 67.69 (+0.60), IYZ: 30.91 (+0.12), SPY: 209.78 (+0.86), IDU: 113.30 (-1.71), REM: 11.74 (+0.04), TYL: 116.28 (+1.36), IDXX: 159.08 (+1.72), IYW: 107.68 (+0.94)
Can Pharma ETFs Continue Their Uptrend In 2015?
Zacks Funds - Seeking Alpha - Fri Jan 09, 4:37PM CST
The pharmaceutical sector, which had been witnessing several tax inversion deals over the last few months, is not likely to go down this route given the Sep 2014 notice issued by the U.S. Department of the Treasury. New rules imposed by the Treasury...
IHE: 163.48 (+1.38), PPH: 67.69 (+0.60), PJP: 73.81 (+0.69), XPH: 118.58 (+0.98)
Can Pharma ETFs Continue their Uptrend in 2015? - ETF News And Commentary
Zacks Equity Research - ZACKS - Fri Jan 09, 11:00AM CST
Several factors suggest that Pharma ETFs may continue their strong performance this year as well.
IHE: 163.48 (+1.38), PPH: 67.69 (+0.60), PJP: 73.81 (+0.69), XPH: 118.58 (+0.98)
Where Do Cures Reside? The Answer Is In Regenerative Medicine
Life Sciences Report - Seeking Alpha - Fri Jan 09, 7:37AM CST
The practice of medicine is being transformed. The journey has been arduous, but revolutionary stem cell, gene and immunocellular therapies are rapidly moving toward pivotal milestones-and investors in the space should strap in for a rewarding joy...
BBP: 28.36 (+0.12), RXL: 131.80 (+1.10), XBI: 203.40 (+1.36), IHE: 163.48 (+1.38), IHF: 123.33 (-0.30), PPH: 67.69 (+0.60), XHE: 91.74 (+0.76), BBC: 28.98 (+0.18), PTH: 56.26 (+0.35), BBH: 122.45 (+0.86), FHLC: 34.19 (+0.16), IHI: 117.25 (+0.94), CURE: 135.77 (+1.84), FXH: 62.97 (+0.34), VHT: 130.56 (+0.66), RYH: 148.64 (+0.75), PBE: 52.78 (+0.30), IYH: 149.63 (+0.84), FBT: 110.21 (+1.02), XHS: 116.43 (-0.07), XPH: 118.58 (+0.98), XLV: 70.72 (+0.28), SBIO: 27.28 (+0.14), PSCH: 63.77 (+0.26), PJP: 73.81 (+0.69), RXD: 13.98 (-0.26)
Kyle Bass's Assault On Pharma Patents
IP Hawk - at Seeking Alpha - Thu Jan 08, 12:25PM CST
BBP: 28.36 (+0.12), RXL: 131.80 (+1.10), XBI: 203.40 (+1.36), IBB: 323.46 (+3.04), IHE: 163.48 (+1.38), IHF: 123.33 (-0.30), BBC: 28.98 (+0.18), PPH: 67.69 (+0.60), XHE: 91.74 (+0.76), PTH: 56.26 (+0.35), BBH: 122.45 (+0.86), FHLC: 34.19 (+0.16), IHI: 117.25 (+0.94), CURE: 135.77 (+1.84), FXH: 62.97 (+0.34), VHT: 130.56 (+0.66), RYH: 148.64 (+0.75), PBE: 52.78 (+0.30), IYH: 149.63 (+0.84), FBT: 110.21 (+1.02), XHS: 116.43 (-0.07), XPH: 118.58 (+0.98), XLV: 70.72 (+0.28), SBIO: 27.28 (+0.14), PSCH: 63.77 (+0.26), PJP: 73.81 (+0.69), RXD: 13.98 (-0.26)
Pharma ETFs In Focus On Allergan Takeover Deal
Zacks Funds - at Seeking Alpha - Sat Nov 22, 9:10PM CST
The health care space is witnessing 2014 as another banner year thanks to encouraging industry trends, solid corporate earnings and huge levels of merger and acquisition activities. The sector is clearly leading the broad market rally and this trend...
IHE: 163.48 (+1.38), AGN: 229.49 (+1.87), PPH: 67.69 (+0.60), ACT: 285.37 (+3.71), XPH: 118.58 (+0.98)
The Zacks Analyst Blog Highlights: Actavis, Allergan, iShares U.S. Pharmaceuticals ETF, Market Vectors Pharmaceutical ETF and SPDR S&P Pharmaceuticals ETF
PR Newswire - Wed Nov 19, 8:30AM CST
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the Actavis (NYSE:ACT-Free Report), Allergan (NYSE:AGN-Free Report), iShares U.S. Pharmaceuticals ETF (AMEX:IHE-Free Report), Market Vectors Pharmaceutical ETF (AMEX
PH-Free Report) and SPDR S&P Pharmaceuticals ETF (AMEX:XPH-Free Report).
AGN: 229.49 (+1.87), PPH: 67.69 (+0.60)
Pharma ETFs in Focus on Allergan Takeover Deal - ETF News And Commentary
Sweta Killa - ZACKS - Tue Nov 18, 12:00PM CST
Pharma ETFs could get further boost from Actavis and Allergan merger deal in the coming days.
IHE: 163.48 (+1.38), AGN: 229.49 (+1.87), VRX: 167.00 (-0.50), PPH: 67.69 (+0.60), ACT: 285.37 (+3.71), XPH: 118.58 (+0.98)
Big Pharma Solid Q3 Earnings Put These ETFs in Focus - ETF News And Commentary
Sweta Killa - ZACKS - Thu Oct 30, 1:00PM CDT
Pharma ETFs have been surging over the past one week buoyed by solid earnings from big industry players.
IHE: 163.48 (+1.38), JNJ: 99.62 (+1.18), PPH: 67.69 (+0.60), PJP: 73.81 (+0.69), MRK: 58.81 (-0.07), LLY: 70.56 (+0.03), BMY: 60.04 (+0.56)
Healthcare ETFs in Focus on JNJ Earnings Beat - ETF News And Commentary
Sweta Killa - ZACKS - Wed Oct 15, 12:00PM CDT
Investors should take a close look to healthcare ETFs following Johnson & Johnson earnings beat.
JNJ: 99.62 (+1.18), PPH: 67.69 (+0.60), IYH: 149.63 (+0.84), GILD: 101.90 (+1.10), ABBV: 58.05 (+1.00), XLV: 70.72 (+0.28)
Market Vectors Equity ETFs Announce September 2014 Distributions
Business Wire - Tue Sep 30, 5:35PM CDT
Van Eck Associates Corporation announced today its regular distributions per share for the Market Vectors equity exchange-traded funds.
PPH: 67.69 (+0.60)
Pfizer Set to Acquire Hospira: Healthcare ETFs in Focus - ETF News And Commentary
Sweta Killa - Zacks Investment Research - Fri Feb 06, 9:00AM CST
Healthcare ETFs are worth a look given that Pfizer will buy Hospira.
IHE: 163.48 (+1.38), PPH: 67.69 (+0.60), IYH: 149.63 (+0.84), PFE: 34.64 (-0.23), HSP: 87.35 (unch), XLV: 70.72 (+0.28)
Big Pharma Weak Guidance Put These ETFs in Focus - ETF News And Commentary
Sweta Killa - Zacks Investment Research - Thu Feb 05, 10:00AM CST
How pharma ETFs are looking after the string of earnings beat and disappointing guidance?
IHE: 163.48 (+1.38), JNJ: 99.62 (+1.18), PPH: 67.69 (+0.60), PJP: 73.81 (+0.69), MRK: 58.81 (-0.07), PFE: 34.64 (-0.23), LLY: 70.56 (+0.03), BMY: 60.04 (+0.56)
New Year Kicks Off With New Fears To Keep Investors On Edge
Scott Martindale - Seeking Alpha - Tue Jan 20, 4:47AM CST
As widely expected, the new year has begun with a lot of volatility on high trading volume, as investors fear more than just a mild correction to start out the year. Despite the strong fundamentals here in the U.S., there are plenty of dangers around...
IYK: 106.66 (-0.09), IYJ: 109.15 (+0.67), ACT: 285.37 (+3.71), IYH: 149.63 (+0.84), IYM: 86.13 (+0.83), UNH: 109.44 (-0.40), PSA: 202.61 (-1.18), IYC: 142.85 (+0.77), SMH: 56.39 (+0.33), NXPI: 84.79 (-0.60), IT: 81.53 (+1.64), IYF: 90.01 (-0.04), IYE: 46.47 (+0.95), LUV: 43.30 (-0.20), JLL: 161.15 (+0.18), PPH: 67.69 (+0.60), IYZ: 30.91 (+0.12), SPY: 209.78 (+0.86), IDU: 113.30 (-1.71), REM: 11.74 (+0.04), TYL: 116.28 (+1.36), IDXX: 159.08 (+1.72), IYW: 107.68 (+0.94)
Can Pharma ETFs Continue Their Uptrend In 2015?
Zacks Funds - Seeking Alpha - Fri Jan 09, 4:37PM CST
The pharmaceutical sector, which had been witnessing several tax inversion deals over the last few months, is not likely to go down this route given the Sep 2014 notice issued by the U.S. Department of the Treasury. New rules imposed by the Treasury...
IHE: 163.48 (+1.38), PPH: 67.69 (+0.60), PJP: 73.81 (+0.69), XPH: 118.58 (+0.98)
Can Pharma ETFs Continue their Uptrend in 2015? - ETF News And Commentary
Zacks Equity Research - ZACKS - Fri Jan 09, 11:00AM CST
Several factors suggest that Pharma ETFs may continue their strong performance this year as well.
IHE: 163.48 (+1.38), PPH: 67.69 (+0.60), PJP: 73.81 (+0.69), XPH: 118.58 (+0.98)
Where Do Cures Reside? The Answer Is In Regenerative Medicine
Life Sciences Report - Seeking Alpha - Fri Jan 09, 7:37AM CST
The practice of medicine is being transformed. The journey has been arduous, but revolutionary stem cell, gene and immunocellular therapies are rapidly moving toward pivotal milestones-and investors in the space should strap in for a rewarding joy...
BBP: 28.36 (+0.12), RXL: 131.80 (+1.10), XBI: 203.40 (+1.36), IHE: 163.48 (+1.38), IHF: 123.33 (-0.30), PPH: 67.69 (+0.60), XHE: 91.74 (+0.76), BBC: 28.98 (+0.18), PTH: 56.26 (+0.35), BBH: 122.45 (+0.86), FHLC: 34.19 (+0.16), IHI: 117.25 (+0.94), CURE: 135.77 (+1.84), FXH: 62.97 (+0.34), VHT: 130.56 (+0.66), RYH: 148.64 (+0.75), PBE: 52.78 (+0.30), IYH: 149.63 (+0.84), FBT: 110.21 (+1.02), XHS: 116.43 (-0.07), XPH: 118.58 (+0.98), XLV: 70.72 (+0.28), SBIO: 27.28 (+0.14), PSCH: 63.77 (+0.26), PJP: 73.81 (+0.69), RXD: 13.98 (-0.26)
Kyle Bass's Assault On Pharma Patents
IP Hawk - at Seeking Alpha - Thu Jan 08, 12:25PM CST
BBP: 28.36 (+0.12), RXL: 131.80 (+1.10), XBI: 203.40 (+1.36), IBB: 323.46 (+3.04), IHE: 163.48 (+1.38), IHF: 123.33 (-0.30), BBC: 28.98 (+0.18), PPH: 67.69 (+0.60), XHE: 91.74 (+0.76), PTH: 56.26 (+0.35), BBH: 122.45 (+0.86), FHLC: 34.19 (+0.16), IHI: 117.25 (+0.94), CURE: 135.77 (+1.84), FXH: 62.97 (+0.34), VHT: 130.56 (+0.66), RYH: 148.64 (+0.75), PBE: 52.78 (+0.30), IYH: 149.63 (+0.84), FBT: 110.21 (+1.02), XHS: 116.43 (-0.07), XPH: 118.58 (+0.98), XLV: 70.72 (+0.28), SBIO: 27.28 (+0.14), PSCH: 63.77 (+0.26), PJP: 73.81 (+0.69), RXD: 13.98 (-0.26)
Pharma ETFs In Focus On Allergan Takeover Deal
Zacks Funds - at Seeking Alpha - Sat Nov 22, 9:10PM CST
The health care space is witnessing 2014 as another banner year thanks to encouraging industry trends, solid corporate earnings and huge levels of merger and acquisition activities. The sector is clearly leading the broad market rally and this trend...
IHE: 163.48 (+1.38), AGN: 229.49 (+1.87), PPH: 67.69 (+0.60), ACT: 285.37 (+3.71), XPH: 118.58 (+0.98)
The Zacks Analyst Blog Highlights: Actavis, Allergan, iShares U.S. Pharmaceuticals ETF, Market Vectors Pharmaceutical ETF and SPDR S&P Pharmaceuticals ETF
PR Newswire - Wed Nov 19, 8:30AM CST
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the Actavis (NYSE:ACT-Free Report), Allergan (NYSE:AGN-Free Report), iShares U.S. Pharmaceuticals ETF (AMEX:IHE-Free Report), Market Vectors Pharmaceutical ETF (AMEX
PH-Free Report) and SPDR S&P Pharmaceuticals ETF (AMEX:XPH-Free Report). AGN: 229.49 (+1.87), PPH: 67.69 (+0.60)
Pharma ETFs in Focus on Allergan Takeover Deal - ETF News And Commentary
Sweta Killa - ZACKS - Tue Nov 18, 12:00PM CST
Pharma ETFs could get further boost from Actavis and Allergan merger deal in the coming days.
IHE: 163.48 (+1.38), AGN: 229.49 (+1.87), VRX: 167.00 (-0.50), PPH: 67.69 (+0.60), ACT: 285.37 (+3.71), XPH: 118.58 (+0.98)
Big Pharma Solid Q3 Earnings Put These ETFs in Focus - ETF News And Commentary
Sweta Killa - ZACKS - Thu Oct 30, 1:00PM CDT
Pharma ETFs have been surging over the past one week buoyed by solid earnings from big industry players.
IHE: 163.48 (+1.38), JNJ: 99.62 (+1.18), PPH: 67.69 (+0.60), PJP: 73.81 (+0.69), MRK: 58.81 (-0.07), LLY: 70.56 (+0.03), BMY: 60.04 (+0.56)
Healthcare ETFs in Focus on JNJ Earnings Beat - ETF News And Commentary
Sweta Killa - ZACKS - Wed Oct 15, 12:00PM CDT
Investors should take a close look to healthcare ETFs following Johnson & Johnson earnings beat.
JNJ: 99.62 (+1.18), PPH: 67.69 (+0.60), IYH: 149.63 (+0.84), GILD: 101.90 (+1.10), ABBV: 58.05 (+1.00), XLV: 70.72 (+0.28)
Market Vectors Equity ETFs Announce September 2014 Distributions
Business Wire - Tue Sep 30, 5:35PM CDT
Van Eck Associates Corporation announced today its regular distributions per share for the Market Vectors equity exchange-traded funds.
PPH: 67.69 (+0.60)
